We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Spadel SA | EU:SPA | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 179.00 | 176.00 | 194.00 | 0.00 | 15:30:16 |
Hot Features
Premium
SR Pharma plc
Holding in Company
London 16 December 2003 - SR Pharma plc ("the Company") was informed today by
the Royal Bank of Scotland Group plc that the Royal Bank of Scotland Group plc
and its subsidiaries had a notifiable interest in 946,286 ordinary 1p shares in
the Company, representing approximately 3.96 per cent of the issued ordinary
share capital.
Further information
Melvyn Davies
Company Secretary
SR Pharma plc
Tel: 020 7307 1620
END
1 Year Spadel Chart |
1 Month Spadel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
